Edwin de Graaf - Managing Partner @ Gilde Healthcare

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

229,636

Primary Job Title Managing Partner
Primary Organization
Gilde Healthcare

Location Utrecht, Utrecht, The Netherlands
Regions European Union (EU), Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Edwin de Graaf is managing director and general partner of Gilde Healthcare Partners and holds a masters degree in business and fiscal economics from the Erasmus University Rotterdam. He currently serves on the board of Pieris AG and served on the boards of GlycArt AG (trade sale to Roche) and AMT (Euronext: AMT).

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Tagworks Pharmaceuticals	Gilde Healthcare	Yes	Series A - Tagworks Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Withings	Gilde Healthcare	Yes	Series B - Withings	obfuscated obfuscation
obfuscated obfuscation	Santaris Pharma	Gilde Healthcare	—	Venture Round - Santaris Pharma	obfuscated obfuscation
obfuscated obfuscation	Prosonix	Gilde Healthcare	—	Series B - Prosonix	obfuscated obfuscation
obfuscated obfuscation	Prosonix	Gilde Healthcare	—	Series B - Prosonix	obfuscated obfuscation
obfuscated obfuscation	Santaris Pharma	Gilde Healthcare	No	Series C - Santaris Pharma	obfuscated obfuscation
obfuscated obfuscation	Roche Glycart	Gilde Healthcare	Yes	Series A - Roche Glycart	obfuscated obfuscation
obfuscated obfuscation	Pieris	Gilde Healthcare	Yes	Series A - Pieris	obfuscated obfuscation

Jobs

Number of Current Jobs

Edwin de Graaf

is the

Managing Partner

Gilde Healthcare

Gilde Healthcare Managing PartnerJul 2006

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Edwin de Graaf

holds

board and advisor roles including

Board of Directors

Prosonix

Board of Directors

Santaris Pharma

, and

Board Member

Tagworks Pharmaceuticals

Prosonix Board of Directors
Santaris Pharma Board of Directors
Tagworks Pharmaceuticals Board Member
Pieris Board of Directors

Organization Name	Title At Company	Start Date	End Date
Roche Glycart	Board of Directors	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Europe, Middle East, and Africa (EMEA) Investors with Funds Raised in 2026	26,810
Utrecht Investors	82,258
European Union (EU) Investors with Funds Raised in 2011	85,590
European Union (EU) Investors with Funds Raised in 2013	39,843
European Union (EU) Investors with Funds Raised in 2022	41,414
Early Stage Venture Investors with Investments in Utrecht, Utrecht	30,521
Europe, Middle East, and Africa (EMEA) Investors with Funds Raised in 2011	73,800
Europe Investors with Funds Raised in 2006	57,889
Early Stage Venture Investors with Investments in Utrecht	18,713
City of Utrecht Investors	94,296